Intrinsic and Effective Severity of Coronavirus Disease 2019 Cases Infected With the Ancestral Strain and Omicron BA.2 Variant in Hong Kong

被引:15
|
作者
Wong, Jessica Y. [1 ]
Cheung, Justin K. [1 ]
Lin, Yun [1 ]
Bond, Helen S. [1 ]
Lau, Eric H. Y. [1 ,2 ]
Ip, Dennis K. M. [1 ]
Cowling, Benjamin J. [1 ,2 ,3 ]
Wu, Peng [1 ,2 ]
机构
[1] Univ Hong Kong, Li Ka Shing Fac Med, WHO Collaborating Ctr Infect Dis Epidemiol & Contr, Sch Publ Hlth, Hong Kong, Peoples R China
[2] Lab Data Discovery Hlth Ltd, Hong Kong Sci & Technol Pk, Hong Kong, Peoples R China
[3] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, 7 Sassoon Rd, Hong Kong, Peoples R China
来源
JOURNAL OF INFECTIOUS DISEASES | 2023年 / 228卷 / 09期
关键词
COVID-19; SARS-CoV-2; intrinsic; Omicron; severity; HOSPITALIZATION FATALITY RISK; INFLUENZA A(H1N1)PDM09; SARS-COV-2; COVID-19; CHINA;
D O I
10.1093/infdis/jiad236
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Evaluating changes in COVID-19 severity over time is crucial when novel variants emerge. Intrinsic fatality risk was similar between Omicron and ancestral strains. Risk was inversely proportional to number of doses received, and higher risk was observed in older ages. Background Understanding severity of infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its variants is crucial to inform public health measures. Here we used coronavirus disease 2019 (COVID-19) patient data from Hong Kong to characterize the severity profile of COVID-19. Methods Time-varying and age-specific effective severity measured by case hospitalization risk and hospitalization fatality risk was estimated with all individual COVID-19 case data collected in Hong Kong from 23 January 2020 through 26 October 2022 over 6 epidemic waves. The intrinsic severity of Omicron BA.2 was compared with the estimate for the ancestral strain with the data from unvaccinated patients without previous infections. Results With 32 222 COVID-19 hospitalizations and 9669 deaths confirmed over 6 epidemic waves, the time-varying hospitalization fatality risk dramatically increased from <10% before the largest fifth wave of Omicron BA.2 to 41% during the peak of the fifth wave when hospital resources were severely constrained. The age-specific fatality risk in unvaccinated hospitalized Omicron cases was comparable to the estimates for unvaccinated cases with the ancestral strain. During epidemics predominated by Omicron BA.2, fatality risk was highest among older unvaccinated patients. Conclusions Omicron has comparable intrinsic severity to the ancestral Wuhan strain, although the effective severity is substantially lower in Omicron cases due to vaccination.
引用
收藏
页码:1231 / 1239
页数:9
相关论文
共 50 条
  • [41] Screening Hesitancy of a Universal Voluntary-based Rapid Antigen Test for coronavirus disease 2019 (COVID-19) During Omicron Wave in Hong Kong
    Wong, Eliza Lai-yi
    Qiu, Hong
    Wang, Kailu
    Sun, Kai-sing
    Yam, Carrie Ho-kwan
    Cheung, Annie Wai-ling
    Yeoh, Eng-kiong
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2023, 16 (08) : 1306 - 1312
  • [42] Long-term oral ACEI/ARB therapy is associated with disease severity in elderly COVID-19 omicron BA.2 patients with hypertension
    Zhang, Zhe
    Wu, Shengyong
    Wang, Zhiyong
    Wang, Yue
    Chen, Hui
    Wu, Cheng
    Xiong, Lize
    BMC INFECTIOUS DISEASES, 2023, 23 (01)
  • [43] Long-term oral ACEI/ARB therapy is associated with disease severity in elderly COVID-19 omicron BA.2 patients with hypertension
    Zhe Zhang
    Shengyong Wu
    Zhiyong Wang
    Yue Wang
    Hui Chen
    Cheng Wu
    Lize Xiong
    BMC Infectious Diseases, 23
  • [44] Residential Clustering of Coronavirus Disease 2019 Cases and Efficiency of Building-Wide Compulsory Testing Notices as a Transmission Control Measure in Hong Kong
    Young, Benjamin R.
    Yang, Bingyi
    Wu, Peng
    Adam, Dillon C.
    Wong, Jessica Y.
    Ho, Faith
    Gao, Huizhi
    Lau, Eric H. Y.
    Leung, Gabriel M.
    Cowling, Benjamin J.
    JOURNAL OF INFECTIOUS DISEASES, 2023, 228 (04): : 426 - 430
  • [45] Reduced clinical severity during 2022 Shanghai Spring epidemic of SARS-CoV-2 omicron BA.2 variant infection——an integrated account of virus pathogenicity and vaccination effectiveness
    Xingyue Wu
    Yao Chen
    Kangli Cao
    Yao Shen
    Xueling Wu
    Yilin Yang
    Zhongshu Kuang
    Qingrun Li
    Zhenzhen Lu
    Yichen Jia
    Mian Shao
    Guorong Gu
    Xiangwei Wang
    Ye Yao
    Ying Wang
    Shaodie Chen
    Zhigao Yu
    Wei Wei
    Longfei Ding
    Lulu Lan
    Tianwen Gu
    Xiangyu Long
    Jian Sun
    Lingyu Xing
    Jiayuan Shen
    Yi Han
    Yue Luo
    Sucheng Mu
    Mengna Lin
    Xiaoyan Zhang
    Rong Zeng
    Jianqing Xu
    Guoping Zhao
    Lihong Huang
    Zhenju Song
    National Science Review, 2024, 11 (04) : 24 - 27
  • [46] SARS-CoV-2 Omicron variant BA. 2 neutralisation in sera of people with Comirnaty or CoronaVac vaccination, infection or breakthrough infection, Hong Kong, 2020 to 2022
    Cheng, Samuel M. S.
    Mok, Chris Ka Pun
    Chan, Karl C. K.
    Ng, Susanna S.
    Lam, Bosco H. S.
    Luk, Leo L. H.
    Ko, Fanny W.
    Chen, Chunke
    Yiu, Karen
    Li, John K. C.
    Chan, Ken K. P.
    Tsang, Leo C. H.
    Poon, Leo L. M.
    Hui, David S. C.
    Peiris, Malik
    EUROSURVEILLANCE, 2022, 27 (18) : 14 - 24
  • [47] SARS-CoV-2 Omicron variants BA.1 and BA.2 both show similarly reduced disease severity of COVID-19 compared to Delta, Germany, 2021 to 2022
    Sievers, Claudia
    Zacher, Benedikt
    Ullrich, Alexander
    Huska, Matthew
    Fuchs, Stephan
    Buda, Silke
    Haas, Walter
    Diercke, Michaela
    an der Heiden, Matthias
    Kroeger, Stefan
    EUROSURVEILLANCE, 2022, 27 (22)
  • [48] Reduced clinical severity during 2022 Shanghai Spring epidemic of SARS-CoV-2 omicron BA.2 variant infection-an integrated account of virus pathogenicity and vaccination effectiveness
    Wu, Xingyue
    Chen, Yao
    Cao, Kangli
    Shen, Yao
    Wu, Xueling
    Yang, Yilin
    Kuang, Zhongshu
    Li, Qingrun
    Lu, Zhenzhen
    Jia, Yichen
    Shao, Mian
    Gu, Guorong
    Wang, Xiangwei
    Yao, Ye
    Wang, Ying
    Chen, Shaodie
    Yu, Zhigao
    Wei, Wei
    Ding, Longfei
    Lan, Lulu
    Gu, Tianwen
    Long, Xiangyu
    Sun, Jian
    Xing, Lingyu
    Shen, Jiayuan
    Han, Yi
    Luo, Yue
    Mu, Sucheng
    Lin, Mengna
    Zhang, Xiaoyan
    Zeng, Rong
    Xu, Jianqing
    Zhao, Guoping
    Huang, Lihong
    Song, Zhenju
    NATIONAL SCIENCE REVIEW, 2024, 11 (04)
  • [49] Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study
    Tsang, Nicole Ngai Yung
    So, Hau Chi
    Cowling, Benjamin J.
    Leung, Gabriel M.
    Ip, Dennis Kai Ming
    LANCET INFECTIOUS DISEASES, 2023, 23 (04): : 421 - 434
  • [50] Characterization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Shedding and Predictors of Viral Culture Positivity on Vaccinated Healthcare Workers With Mild Coronavirus Disease 2019
    Luna-Muschi, Alessandra
    Noguera, Saidy Vasconez
    Borges, Igor C.
    De Paula, Anderson, V
    Cortes, Marina Farrel
    Larocca, Carolina
    Mari, Julia Ferreira
    Pereira Guimaraes, Lara Silva
    Torres, Pablo Munoz
    Scaccia, Nazareno
    Villas-Boas, Lucy S.
    da Silva Jr, Almir Ribeiro
    Andrade, Pamela S.
    Teixeira, Juliana C.
    Escadafal, Camille
    de Oliveira, Vitor Falcao
    Tozetto-Mendoza, Tania R.
    Mendes-Correa, Maria Cassia
    Levin, Anna S.
    Sabino, Ester C.
    Costa, Silvia F.
    JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (10): : 1726 - 1730